Block Engineering to Develop QCL System with Pfizer
Block Engineering has partnered with Pfizer Inc. to develop a quantum cascade laser (QCL) based infrared spectroscopy system for noncontact cleaning verification of vessels during pharmaceutical manufacturing.
The technology leverages Block Engineering’s LaserScan analyzer to provide a handheld, battery-operated bar-code-scanner-like device that provides real-time, noncontact cleaning verification of vessels to avoid cross-contamination between products. Current methods to ensure that vessel walls meet strict FDA cleanliness standards involve swab-based techniques that require several hours to collect samples and send them to offline instruments such as high-pressure liquid chromatography systems.
“Cleaning verification is a critical step in the drug manufacturing process, and Pfizer is committed to the development of technologies that could decrease inspection times, reduce costs and improve supply assurance,” said Steve Hammond, head of the Process Analytical Sciences Group and senior director in the Global Manufacturing Services organization at Pfizer.
The novel approach is expected to reduce labor, material and consumables in addition to plant downtime.
“Block’s QCL-based infrared spectrometers are opening new markets, and cleaning verification is one of the most exciting and high-impact applications,” said Block Engineering CEO Petros Kotidis.
For more information, visit:
www.blockeng.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024